Logo
x

Search

Subscribe Now

Biontech

BioNTech Reports the Lifting of Partial Clinical Hold for BNT326/YL202

BioNTech Reports the Lifting of Partial Clinical Hold for BNT326/YL202

  • August 20, 2024
BioNTech Reports Topline Data from P-II Study of BNT111 to Treat Advanced Melanoma Patients

BioNTech Reports Topline Data from P-II Study of BNT111 to Treat Advanced Melanoma Patients

  • July 31, 2024
BioNTech and DualityBio Report the Initiation of P-III Trial for BNT323/DB-1303 to Treat Metastatic Breast Cancer

BioNTech and DualityBio Report the Initiation of P-III Trial for BNT323/DB-1303 to Treat Metastatic Breast Cancer

  • January 23, 2024
Moderna's Patent Revoked by the European Patent Office (EPO) due to BioNTech Vaccine Dispute

Moderna's Patent Revoked by the European Patent Office (EPO) due to BioNTech Vaccine Dispute

  • November 22, 2023
PharmaShots Weekly Snapshots (October 09–13, 2023) _

PharmaShots Weekly Snapshots (October 09–13, 2023) _

  • October 14, 2023
BioNTech and OncoC4 Initiate Pivotal P-III Trial of Gotistobart (BNT316/ONC-392) in Patients with Metastatic Non Small Cell Lung Cancer

BioNTech and OncoC4 Initiate Pivotal P-III Trial of Gotistobart (BNT316/ONC-392) in Patients with Metastatic Non Small Cell Lung C...

  • June 30, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.